Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia
- 22 May 2007
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 108 (3), 409-416
- https://doi.org/10.1007/s10549-007-9609-5
Abstract
Efficacy of breast screening may differ in practice from the results of randomized trials. We report one of the largest case–control evaluations of a screening service. Subjects included 491 breast-cancer deaths affecting 45–80-year-old South Australian females during 2002–2005 (diagnosed after BreastScreen commencement) and 1,473 live controls (three per death) randomly selected from the State Electoral Roll after birth-date matching. Cancer Registry and BreastScreen records provided cancer and screening details. Risk estimates were calculated by BreastScreen participation, using conditional logistic regression. Interpretation was assisted by a population survey of risk factor prevalence by BreastScreen participation in 1,684 females aged ≥40 years. The relative odds (OR) (95% confidence limits) of breast-cancer death in BreastScreen participants compared with non-participants were 0.59 (0.47, 0.74). Compared with non-participants, the OR was 0.70 (0.47, 1.05) for women last screened through BreastScreen more than 3 years before diagnosis of the index case, and 0.57 (0.44, 0.72) for women screened more recently. The OR of 0.47 (0.34, 0.65) for women screened more frequently in the pre-diagnosis phase was lower than the 0.64 (0.50, 0.82) for other screened women. The overall OR of 0.59 approximated 0.70 when corrected for the screening self-selection bias observed in five randomized trials. However, multivariable analysis of survey data did not indicate a lower prevalence of breast-cancer risk factors among BreastScreen participants, suggesting that this correction may be inappropriate. Participation in screening was associated with a breast-cancer mortality reduction of between 30 and 41%, depending on assumptions about screening self-selection bias. A downward mortality risk by recency of last screen prior to cancer diagnosis, and frequency of recent screening, is consistent with a screening effect.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy of Breast Cancer Screening in the Community According to Risk LevelJNCI Journal of the National Cancer Institute, 2005
- Evaluation of service screening mammography in practice: the impact on breast cancer mortalityAnnals of Oncology, 2005
- A case-control study to estimate the impact on breast cancer death of the breast screening programme in WalesJournal of Medical Screening, 2004
- Mammographic screening: case–control studiesAnnals of Oncology, 2003
- Empirical Comparison of the Results of Randomized Controlled Trials and Case-Control Studies in Evaluating the Effectiveness of Screening MammographyJournal of Clinical Epidemiology, 1998
- Breast cancer screening with mammography: overview of Swedish randomised trialsThe Lancet, 1993
- Case-Control Evaluation of Breast Cancer Screening EfficacyAmerican Journal of Epidemiology, 1991
- Randomized study of mammography screening — preliminary report on mortality in the stockholm trialBreast Cancer Research and Treatment, 1991
- Edinburgh trial of screening for breast cancer: mortality at seven yearsThe Lancet, 1990
- Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.BMJ, 1988